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Summary 
A defining characteristic of superantigens is their ability to stimulate T cells based predominantly 
on the type of variable segment of the T cell receptor (TCK) B chain (V3). The VB specificity 
of these toxins most likely results from direct contact between the toxin and the TCR, although 
the low affinity nature of this binding has prevented direct assessment of this interaction.  To 
identify important functional sites on the toxin, we created chimeric enterotoxin genes between 
staphylococcal enterotoxins A and E (SEA and SEE) and tested the VB specificity of the chimeric 
toxins. This approach allowed us to identify three amino acid residues in the extreme COOH 
terminus of these toxins that are largely responsible for their ability to stimulate either human 
VB5- or VB8-bearing T cells, or mouse V~3 or VBll. We also found that residues in the NH2 
terminus were required for wild-type levels of VB-specific T cell activation, suggesting that the 
NH2 and COOH ends of these superantigens may come together to form the full TCR V/~ 
contact site. SEA and SEE also differ with respect to their class II binding characteristics. Using 
the same chimeric molecules, we demonstrate that the first third of the molecule controls the 
class II binding phenotype. These data lead us to propose that for SEA and SEE, and perhaps 
for all bacterial-derived superantigens, the COOH and NH2 termini together form the contact 
sites for the TCR and therefore largely determine the V~ specificity of the toxin,  while the 
NH2  terminus  alone  binds  major  histocompatibility  complex  class  II  molecules.  The 
predominant role of the COOH terminus of  bacterial superantigens in determining  VB specificity 
resembles current models being proposed for vitally encoded superantigens, suggesting that these 
molecules may demonstrate some structural  relationship  not seen at the amino acid level. 
S 
uperantigens are a family of  T cell mitogens that are unique 
in two respects: first, they require the presence of MHC 
class II molecules to effectively activate T cells; and second, 
the T cells that respond to them share one or a few variable 
segments of the TCR VB chain (1-6). One class of proteins 
that demonstrates  such characteristics are exotoxins derived 
from Staphylococcus aureus and Streptococcus pyogenes  (staphyl- 
ococcal enterotoxin [SE]  1 A through E, toxic shock toxin 
[TSST-1], and streptococcal pyrogenic exotoxins A and C). 
A second superantigen family consists of the proteins encoded 
by the 3' LTR of mouse mammary  tumor viruses (MMTVs). 
Superantigen activation of T cells in a VB-specific manner, 
with only limited regard for the make up of the other vari- 
able segments of the TCR (D~, J~/, Vcr  Joe), has been pre- 
sumed to be due to direct contact between the toxin and the 
TCR VB chain. Indeed,  the contact site on TCRs by bac- 
1  Abbreviations used in this paper: GAM, goat anti-mouse; SE, staphy- 
lococcal enterotoxin; SOE, splicing  by overlap extension. 
terial and viral superantigens has been mapped and shown 
to lie outside the site of the TCR thought to contact conven- 
tional peptide antigen/MHC complexes (7, 8). Several  years 
ago we and others demonstrated direct binding between bac- 
terial superantigens and MHC class II molecules (9-11). This 
binding reaction is of moderately high affinity, especially  with 
SEA and HLA-DR, making it a relatively easy interaction 
to study functionally and map biochemically (12). However, 
direct binding between toxins and TCRs has been much more 
difficult to demonstrate.  This reaction,  therefore, must be 
of lower affinity  and/or more transient,  although  direct 
binding between bacterial superantigen/class II complexes and 
isolated  TCR  /3  chains  has  been  reported  (13). As  our 
mechanistic understanding of toxin-mediated T cell activa- 
tion has increased, it is easy to understand why previous ap- 
proaches of looking for mitogenic fragments of these mole- 
cules failed to provide convincing results. T cell activation 
by superantigens requires both class II binding and the TCR 
contact site on the same molecule. Therefore, a reductionist 
approach, finding smaller and smaller mitogenic fragments, 
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less a single fragment were to possess both activities. 
Besides the in vitro activities  most often studied, such as 
T cell proliferation, VB-specific T cell activation, and MHC 
class II binding, the SEs and TSST-1 cause a number of in 
vivo effects, such as fever production (14), emesis (15), and 
toxic shock (16, 17), that may reflect one or several of these 
in vitro activities.  Consequently, it would be of substantial 
interest to construct mutant SEs that completely lacked, for 
example, the ability to activate T cells yet retained the ability 
to bind class II molecules and then test for the correlative 
loss of in vivo activities.  To construct such mutations, one 
first must map the regions of the toxin that directly mediate 
these in vitro activities  and then create  discrete  mutations 
that effectively eliminate one activity while preserving others. 
Recently, Kappler et al. (18) advanced a structure-function 
model of the related enterotoxin SEB. Using a random muta- 
genesis approach,  these investigators  reported that mutations 
affecting both MHC class II binding and TCR. interaction/acti- 
vation clustered to the NH2 terminus of the molecule. These 
data led them to propose that these two critical immunolog- 
ical functions are intertwined at the NH2-terminal end of 
the molecule. If this model is correct then hopes of con- 
structing mutants with selective loss of one of these func- 
tions may be misfounded. However, previous data from our 
laboratory had suggested that class II binding and TCR con- 
tact activities were dissociable (19, 20). Therefore, we sought 
to map these two activities using a different genetic approach 
to determine whether they are indeed intertwined or not. 
To map functional regions of bacterial superantigens, we 
took  the  approach  of constructing  intragenic  SEA/SEE 
chimeras.  SEA and SEE, despite their high degree of struc- 
tural similarity (21, 22),  demonstrate reciprocal  patterns of 
VB-specific T cell activation (23), as well as distinct class II 
binding a~nities (24, 25), making them good candidates for 
this type of study. By testing the chimeric molecules for V:/ 
specificity, or class II binding a~nity, we hoped to localize 
the region of one or both molecules that mediates these func- 
tions. In this report, we use this approach to map the region 
of SEA and SEE that controls their VB specificity, and to 
separate this region from that determining class II binding 
af~nity. 
Materials and Methods 
Mice.  8-12-wk-old male B10.BR/SgSnJ mice were obtained 
from The Jackson Laboratory (Bar Harbor,  ME). T  cells were 
purified from spleen cells by lysis  of RBC and adsorption of B cells 
onto goat anti-mouse (GAM) Ig--coated  magnetic beads (Advanced 
Magnetics, Cambridge, MA) as described (20). Purified T cells (2 
x  l@/ml) were stimulated with recombinant toxins and irradi- 
ated (2,000 rad) syngeneic spleen cells (106/ml) for 4 d. Viable 
nonadherent cells were isolated  by lympholyte-M  gradients, washed 
in HBSS, and analyzed by flow cytometry with a panel of FITC- 
labeled, VB-specific  mAbs (Pharmingen, San Diego, CA). Forward 
angle and 90  ~ light-scatter patterns were used to restrict the anal- 
ysis to blast cells. 
Antibodies.  The following murine mAbs were used for isola- 
tion of purified human T cells: L227  (IgG1) and L243 (IgG2a), 
anti-human class II monomorphic determinant; 9.3F10 (IgG2a), 
anti-HLA DR./DQ;  OKM1 (IgG2b), anti-CD11b; LM2/1.6.11 
(IgG1), anti-human MAC-1. All cell lines were obtained from the 
American Type Culture Collection (Rockville, MD). The mAbs 
L227, L243, and LM2/1.6.11 were used as ascites to stain cells at 
a 1:1,000 dilution. OKM1 was used to stain cells as a tissue culture 
supernatant at a 1:20 dilution. Antibodies specific  for human TCR 
VB segments were from the Diversi-T Anti-Human TCR Anti- 
body Kit (T Cell Diagnostics, Cambridge, MA). 
Construction of Chimeric Enterotoxins.  Construction of chimeric 
enterotoxin genes and site-directed  mutagenesis  were accomplished 
by the technique of splicing by overlap extension (SOE) (26, 27). 
The coding regions of the entA (SEA) and entE (SEE) genes were 
subcloned from the plasmids  pMJB117 (22) and pMJB46 (21), respec- 
tively, into the phagmid vector pBluescript II SK(-); these plasmids 
were designated pMV2 and pMV5, respectively  (20). All oligonu- 
deotide primers were obtained form Midland Certified Reagent 
Co. (Midland, TX). To construct a chimeric enterotoxin gene, in- 
ternal PCR primers were designed to provide at least 12 bp of 
priming homology on the two different toxin genes and ",,15 bp 
of overlapping homology with each other. The two fragments of 
the  genes were amplified using the SOE primers and flanking 
primers homologous to the reverse primer (sense orientation) and 
M13-20 primer (antisense  orientation)  sites on the pBluescript vector. 
Primary PCR reactions consisted of 1 #M of each primer, 1 #g 
of template plasmid, 10/~1 of 10x  PCR.  buffer, 200 #M of each 
dNTP in a total volume of 100/~1. For the first several chimeras, 
2.5 U Taq polymerase (Perkin-Elmer Cetus Corp., Norwalk, CT) 
was used along with the 10x  buffer  (Perkin-Elmer Cetus Corp.) 
with a final Mg  2§  concentration of 2.5 mM. For the remaining 
chimeras, 2.5 U of PFU polymerase (Stratagene, La Jolla, CA) per 
reaction was used with 10/~1 of the manufacturer's 10 x buffer no. 
2 (200 mM Tris-C1, pH 8.8, 100 mM KC1, 60 mM [NH412SO4, 
15 mM MgC12, and 1% triton X-100), as PFU polymerase was 
found to introduce far fewer  polymerase  errors than Taq polymerase. 
PCR. reactions were overlayed  with 100 #1 light white mineral oil 
and denatured at 95~  for 5 rain, the polymerase  was then added, 
and reactions were subjected to 27 cycles of amplification (1 min 
at 95~  2 min at 55~  and 3 min at 72~  on a thermocycler 
(Perkin-Elmer Cetus Corp.). The products of the primary PCR 
reaction were separated on a 1.0% agarose gel, and the amplified 
products excised  from the gel and melted in three volumes of 6 M 
NaI,  100  mM NaPO4, 22.2 mM dithiothreitol,  pH  6.0. The 
DNA was isolated from melted agarose on SpinBind cartridges 
(FMC Bioproducts, Rockland, ME) according  to the manufacturer's 
instructions. TypicaLly,  two cartridges were used to purify the prod- 
ucts from one PCR reaction. Each cartridge was eluted with 60/~1 
of water, the eluates from the same reaction were pooled, and the 
DNA was precipitated with 0.1 vol of 3 M sodium acetate and 
2.5 vol ethanol. The toxin fragments were resuspended in 20 #1 
of water and quantitated at OD260. In the secondary PCR reac- 
tion,  1/~g of each of the toxin fragments to be spliced together 
were mixed in a 100-/~1 PCR reaction along with 1 #M of reverse 
primer and M13-20 primer each, 200 #M of each dNTP,  10 ~1 
of 10x buffer,  2.5 U of  polymerase,  and subjected  to 32 amplification 
cycles as described above except that the annealing temperature was 
lowered to 45~  The products of the secondary PCR reaction 
were phenol extracted, ethanol precipitated, and resolubilized in 
32/~1 of water, supplemented with 4 ~1 of appropriate 10 x  en- 
zyme buffer, and digested with 40 U (4/~1) of either BamHI or 
HindlII (Gibco BRL, Gaithersburg, MD). Digestions were car- 
ried out for 2 h at 37~  with phenol extraction and ethanol precipi- 
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tion digestion, the products were separated on a 1.0% agarose gel, 
and the band corresponding to the spliced and digested product 
was excised from the gel. This product could be distinguished from 
the predigested material on the basis of size because of the absence 
of the flanking DNA fragments. The digested fragment was purified 
from the agarose gel on one SpinBind cartridge, eluted in 80/~1 
of  water, and ethanol precipitated. The fragment was resolubilized 
in 15/~1 of water, quantitated at OD~0, and ligated into a BamHI- 
HindlII-digested pBluescript II SK(-) vector at a 10:1 insert-to- 
vector ratio. 0.5-5/~1 of the ligation reaction was used to trans- 
form XL-1 blue-competent cells (200236;  Stratagene) according 
to the manufacturer's instructions. White colonies were screened 
for appropriate insert and orientation by bacterial PCR reactions 
(28) using the flanking primers (reverse and M13-20 primer), as 
well as one of the internal SOE primers used to construct the chi- 
mera. Clones displaying  PCR products of appropriate size were 
chosen for further analysis. All of the chimeric/mutant toxins were 
sequenced in full and found to have no unintended mutations, or 
rarely, silent mutations. DNA sequencing was carried out on single- 
stranded  templates  using  a  Sequenase  dideoxy termination  se- 
quencing kit (U.S. Biochemical Corp., Cleveland,  OH) as previ- 
ously described (20, 29). 
Nomenclature.  Three types of recombinant toxins were made: 
chimeric enterotoxin, region-specific exchange mutants, and point 
mutations. Chimeric enterotoxins were designated according to the 
composition of the NH2- and COOH-terminal regions followed 
by the amino acids at the chimeric junction; e.g., SEE-SEA 70-71 
indicates  a toxin with SEE sequences from amino acids 1-70 and 
SEA sequences from amino acids 71-233. All amino acid numbering 
is according to the SEA sequence (21). Region-specific mutations 
are designated by indicating the substituted stretch of amino acids 
in parenthesis after the toxin of origin; e.g., SEA-SEE (136-149) 
indicates that the amino acids 136-149 of SEE are substituted into 
the SEA molecule at the analogous position. Point mutations are 
indicated by designating the toxin, amino acid position, and amino 
acid mutation; e.g., SEA 200 G-*D represents a mutation of gly- 
cine to aspartic  acid in the SEA molecule at amino acid 200. 
Production of the Ckimeric and Mutant Toxins.  2 liters of2x YT 
media (16 g tryptone, 10 g yeast extract, and 5 g NaC1 per liter) 
containing 100 #g/ml ampicillin  was  inoculated with 75 ml of 
confluent overnight bacterial cultures. The cultures were grown 
to  an  OD600 of  0.9  and  supplemented  with  isopropyl-B-D- 
thiogalactopyranoside (Pierce Chemical Co., Rockford, IL) to a 
final concentration of I  mM. The cultures were returned to the 
incubator and grown with vigorous aeration for 2-4 h. At the end 
of the incubation period bacteria were pelleted at 4,000 rpm for 
20 min at 4~  and resuspended in 20 ml of ice-cold SET (20% 
sucrose,  1  mM  EDTA,  and  20  mM  Tris-C1, pH  7.5).  The 
resuspended bacteria were incubated at 4~  for 15 min, pelleted 
at 4,800 rpm in a rotor (SS34; Sorvall,  Wilmington,  DE)  and 
resuspended in 10 ml of 1 mM EDTA, rocked at 4~  for 45 rain, 
and repelleted at 7,000 rpm for 15 min. The supernatant, hereafter 
referred to as the shockate,  was removed and filtered  (0.45/zm). 
For toxins consisting mostly of SEA-derived sequences, the shockate 
was  diluted  1:2 in  PBS,  pH  7.2,  and purified on an  anti-SEA 
Sepharose column as previously described (20). For chimeric/mu- 
tant toxins consisting mostly of SEE-derived sequences, the shockate 
was concentrated to 1.5 ml, first on a Centriprep 10 and then on 
a Centricon 10 (Amicon Corp., Danvers,  MA). The sample was 
ffactionated on a Superdex 75 gel filtration column in 200 mM 
ammonium bicarbonate using an FPLC system (Pharmacia  LKB 
Biotechnology, Piscataway, NJ). The column was calibrated with 
native SEA to determine the fractions that would contain the ehting 
chimeric toxin. The semipurified  toxin was concentrated to 3 ml 
on a Centricon 10 and desalted into PBS on a DG-10 column (Bio- 
Pad Laboratories, Richmond, CA) according to the manufacturer's 
instructions. Total protein content was determined by the bicin- 
choninic acid assay (BCA) (Pierce Chemical Co.). Toxins prepared 
by affinity chromatography ran  as  single  bands  at  28  kD  on 
Coomassie blue-stained SDS-PAGE gels. Typical yield from 1 liter 
broth (10 ml periplasmic  shockate)  was  "~100 #g. 
V~ Analysis of Toxin-activated  Human T Cells.  PBMC were ob- 
tained from freshly isolated buffy coat packs derived from healthy 
donors (Gulf Coast Blood Center, Houston, TX).  T  cells were 
purified from the PBMC by negative selection using GAM Ig--con- 
jugated magnetic beads (Advanced Magnetics).  Briefly, PBMC were 
stained  with a cocktail of anti-class II and anti-monocyte mAb 
consisting ofL227, L243, 9.3F10, OKMI, and LM2/1.6.11 for 30 
min at 4~  The cells were washed once and incubated with GAM 
Ig magnetic beads at a ratio of 200  x  10  ~ cells/12-ml equivalents 
of GAM Ig beads.  The GAM Ig beads  were washed four times 
in HBSS/2%FCS before use. The cells and beads were incubated 
for at least 2 h with gentle agitation at 4~  After one round of 
negative selection,  the cells typically consisted of >96%  CD3 + 
cells. Purified T cells (106/ml) and autologuus irradiated (1,000 tad) 
unfractionated PBMC (2.5  x  106/ml) were cultured in 5 ml of 
assay media composed of RPMI,  10%  heat-inactivated human 
AB § serum,  100/zg/ml gentamicin,  1%  antibiotic-antimycotic 
mixture, 2 mM t-glutamine, 5 mM Hepes (all components, except 
serum, from Gibco Laboratories,  Grand Island,  NY) in six-well 
dishes (3506; Costar, Cambridge, MA). All affinity-purified recom- 
binant toxins were added to a final concentration of 0.5/~g/ml and 
the gel filtration-purified recombinant toxins were used at a final 
concentration of 5/~g/ml (found to be optimal for each of the prepa- 
rations in preliminary experiments). Native SEA and SEE (Toxin 
Technology, Sarasota,  FL) were added at a final concentration of 
0.5 and 0.25/~g/ml, respectively. The cultures were incubated for 
3 d at 37~  in a humidified incubator with 5% CO2. Viable cells 
were then isolated from the culture on an isolymph gradient and 
recultured in 5 ml of assay media supplemented with 18 ng/ml 
rib2 (R&D Systems, Minneapolis,  MN) or 50 U/ml rlL-2 (Amgen 
Biologicals)  overnight. The following day, 0.5  x  1@ cells were 
stained  with either the indicated anti-V/~ antibody (T cell Diag- 
nostics)  followed by  GAM  Ig(G,M)  FITC  (Fluoricon;  Baxter 
Healthcare Corp., Mundelein, IL), anti-CD3 (Leu-4 FITC; Becton 
Dickinson & Co., Mountain View, CA), or goat anti-mouse Ig 
(G,M) FITC alone.  Cell staining was carried out for 60 rain at 
4~  in PBS/1%FCS/10 mM Hepes/0.025% (wt/vol) sodium azide 
in a total volume of 200 #1. In the initial phase of this study, cells 
were analyzed with the entire panel of anti-V~ antibodies in the 
Diversi-T TCR c~//~ screening panel.  After finding no perturba- 
tion in the percent positive blasts for any of the antibodies except 
for VBS(a) and VB8, the latter part of the study involved staining 
the T cell blasts with only the anti-V/35(a) (clone 1C1, isotype IgG1) 
and anti-V~8 (clone 16G8,  isotype IgG2b) antibodies.  The cells 
were analyzed by flow cytometry on an Epics Profile (Coulter Corp., 
Hialeah, FL) by gating on the blast cell population only. Except 
where indicated, all chimeric/mutant toxins were tested on three 
different donors in the same experiment. Data are expressed as the 
mean value for percent positive cells  +  SEM. 
Class II Binding Assay.  The ability of selected chimeric toxins 
to bind MHC class II molecules directly was assessed using an HLA- 
DKl-transfected fibroblast  cell line,  D.5-3.1 (kindly provided by 
E. Long, National Institutes of Health, Bethesda,  MD). The assay 
was performed essentially  as described  (19), except the assay was 
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pretitered amount of SEA-FITC. 
Proliferation Assay.  Selected  chimeric toxins were assessed for 
their ability to stimulate T cell proliferation by incubating dilu- 
tions of purified chimeric toxins with 8  x  10  ~  PBMC in round- 
bottomed 96-well plates. The cells were cultured for 66 h, with 
1 /zCi [3H]TdR (2 Ci/mmol; DuPont Co., Wilmington, DE) 
added per well for the final 18 h of culture. DNA was harvested 
onto glass fiber filters, and incorporation of [aH]TdR was assessed 
by liquid scintillation counting. 
Results 
V/~ Specificity of  SEA and SEE Maps to the COOH-terminal 
Half of the Molecules.  Previous results from our laboratory 
showed that the central disulfide loop region, highly con- 
served among the enterotoxins,  plays an important role in 
their mitogenicity (19), but does not itself contain the VB 
contact site (20). Therefore, we began by constructing two 
chimeric molecules that were designed to localize the region 
determining the VB specificity of these two enterotoxins to 
one side of the loop region. Both of these chimeras were de- 
signed with SEE sequences at the NH2-terminal portion and 
SEA sequences  at the COOH-terminal portion. The chimeric 
junctions were chosen to be well upstream and downstream 
of the cysteine loop, which in SEA is formed by cysteines 
96 and 106. Analysis  of the V~ specificity  of these two chimeras 
indicated that they both closely resembled the stimulatory 
phenotype of SEA (Fig. 1). Thus, the region of the molecule 
responsible for VB spedfidty mapped to the COOH-terminal 
half of these molecules, downstream of amino acid 123. In- 
terestingly, T cell responses to these chimeras exhibited slightly 
lower levels of V/~5 and slightly elevated levels of VB8 com- 
pared with responses to native SEA. 
To define more precisely the region of the toxins  that 
mediates VB specificity,  we created a series of chimeric toxins 
in which the junction lay progressively further downstream 
from the 122-123 junction. These were constructed in the 
opposite orientation from the initial two to take advantages 
of  the high V(38 signal of  SEE. For chimeric toxins containing 
progressively fewer SEE sequences at the COOH terminus, 
the percentage of VB8 + T cell blasts decreased while that 
of Vfl5 + T cells increased (Fig. 2 A). Some chimeric toxins 
showed an unexpected  phenotype, stimulating significant  levels 
of both Vfl5 + and Vfl8 + T  cells. The most striking ex- 
ample of this was the chimera SEA-SEE 187-188, although 
it was also seen with SEA-SEE 162-163 and to a lesser degree 
with SEA-SEE 142-143. T cell blasts stimulated with SEA- 
SEE 187-188 contained  approximately  equal percentage of 
V35- and Vfl8-bearing  T  cells, although both levels were 
below those seen  with wild-type SEA and SEE, respectively. 
As in the two chimeras shown in Fig. 1, although the COOH 
terminus largely dictated the V3 specificity of chimeras SEA- 
SEE 142-143 and 160-161, the percentage of the V~8 + blasts 
was '~50% that of native SEE. As expected, the reciprocal 
constructs of these two chimeras stimulated predominantly 
V35 + T cells (Fig. 2 B), confirming the importance of the 
COOH terminus in VB specificity.  However, when the SEA- 
SEE chimeric junction was placed at amino acids 219-220, 
the chimera was phenotypically  indistinguishable  from na- 
tive SEA. Because the 160-161 chimera possessed the most 
downstream junction  that  provided  a  clean  reciprocally 
stimulating phenotype, we concluded that the region largely 
responsible for determining  V3 specificity  of these two toxins 
lay downstream of amino acid 161  and upstream of 219. 
Amino Acid Differences between SEA and SEE in the V/~- 
determining Domain Cluster to Four Regions.  Fig. 3 shows an 
amino acid comparison between SEA and SEE in the COOH- 
terminal half of the molecule. Amino acid differences cluster 
to four regions, which we designated regions  1-4. Because 
regions 1-3 contained the greatest number of differences, we 
initially exchanged these regions between the two toxins to 
test the contribution of each to VB specificity independently 
of the other regions. Exchanging region 1, 2, or 3 from SEA 
into SEE or the reciprocal constructions showed no pertur- 
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Figure  1.  The  region of SEA 
and  SEE  that  determines  V/3 
specificity  is located in the COOH- 
terminal half of the molecule. Chi- 
meric enterotoxins with indicated 
amino  acid junctions were  con- 
structed  and  used  to  stimulate 
purified human T cells for 3 d in 
vitro. Responding cells  were stained 
with mAbs specific  for either human 
V~5 or V/~8, and the blast cells  were 
analyzed by flow cytometry for per- 
centage of positive staining cells. In 
this and subsequent figures, unless 
otherwise noted, data shown are the 
mean of three analyses on different 
donors in one experiment  _+ SEM. 
Background staining was not sub- 
tracted. Responding cell populations 
were  >98%  CD3  positive  and 
<0.3% positive when stained with 
GAM Ig FITC alone. A 
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Figure 2.  Chimeric  enterotoxins 
with  progressively downstream 
junctions further define the VB- 
determining region of SEA and 
SEE. All chimeras  were  analyzed  in 
three different  donors  in one experi- 
ment, except  for SEA-SEE 160-161, 
which is the result of six analyses 
in one experiment. 
bation of the VB stimulatory phenotype compared to the 
native  toxin  (Table  1).  The  one  exception  was  SEA- 
SEE(136-149),  which stimulated Vfl8 + T cells significantly 
above background, although this increased  stimulation of 
Vfl8 + T  cells was not accompanied by a concomitant de- 
crease in VB5 stimulation. Moreover, this mixed phenotype 
was  not  observed  with  the  reciprocal  construct  SEE- 
SEA(136-149). Additionally, we mutagenized the internal four 
amino acids in region 3 to alanines but again saw no effect 
on the V/~ stimulatory phenotype (SEA-Ala[190-193]; Table 
1).  Importantly, in all of these mutants, in contrast to the 
chimeras shown in Figs.  1 and 2, we observed  percentages 
of V/35 or VB8 equivalent to those seen in the wild-type 
toxins. From these data we concluded that neither region 1, 
2, nor 3 alone was suf~cient to transfer V/3 specificity from 
one toxin to the other. It was possible  that more than one 
region was required to transfer specificity. For example, regions 
2 and 3 together may convert the V/~ stimulatory phenotype 
of one toxin to another. 
Region 4 Alone  Can Reciprocally Transfer Most of the VI~ 
Stimulatory Phenotype between SEA and SEE.  To investigate 
the possibility that the region required to transfer V/~ specificity 
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is larger than either region 1, 2, or 3 alone, we took the ap- 
proach of  constructing double chimeric molecules, We started 
with SEA-SEE 160-161, because this is the most downstream 
chimera that did not show a mixed phenotype and appended 
the COOH  terminus of SEE from amino acid 196  to the 
end of the molecuIe.  These terminal 38 amino acids contain 
only six amino acid differences between SEA and SEE. Three 
122 123  142 143  160-161  162-163 
~'~:,~o ......  ~----F  ---~---~--~-  ..........  I"--~-'9  .....  ~-~- 
Region 3  Reglon 4 
187-188  195-196  219-220 
Figure 3.  Amino  acid comparison of SEA and SEE in the VB-deter- 
mining domain. Sequence  differences  cluster to four regions. Numbering 
used to designate  chimeric  joints is according  to the SEA molecule  (21). 
SEA and SEE contain  the same number of amino acids in the immature, 
unprocessed protein. Mature SEA, however, contains three extra amino 
acids due to differential  processing of the NH2 terminus. Table  1.  Mutations Exchanging  Regions  1, 2, and 3  between SEA  and SEE Do Not Affect  the  Vfl Stimulatory Phenotype 
Percent positive blasts 
Parental  Region  Region 
Chimera/Toxin  toxin  mutated  mutated  to:  Vfl5  Vfl8 
SEA  -  -  -  4.9  _+  0.6  1.0  _+  0.2 
SEA-SEE(136-149)  SEA  1  SEE  4.5  -+  0.5  4.1  _+  1.2 
SEA-SEE(161-168)  SEA  2  SEE  6.4  _+  0.8  0.7  +  0.1 
SEA-SEE(188-195)  SEA  3  SEE  5.1  +  0.1  0.4  _+  0.0 
SEA-Ala(190-193)  SEA  3  Alanine  5.4  _+ 0.6  0.5  +_ 0.1 
SEE  -  -  -  1.5  _+ 0.3  12.4  _+ 0.2 
SEE-SEA(136-149)  SEE  1  SEA  1.1  _+ 0.3  11.4  +  0.4 
SEE-SEA(161-168)  SEE  2  SEA  0.9  -+  0.2  12.7  _+ 0.5 
SEE-SEA(188-195)  SEE  3  SEA  0.4  _  0.0  11.7  _+ 2.2 
of these amino  acid differences had already been ruled out 
as playing a role in Vfl specificity by the chimera SEA-SEE 
219-220 and the other three differences were encompassed 
by region 4.  We were surprised  to find that  in  these con- 
structs, the flanking regions of the molecule dictated the Vfl 
specificity.  For instance, SEE-SEA(161-195) was phenotypi- 
cally indistinguishable  from native SEE (Fig.  4), ruling out 
a complex Vfl-determining  site comprised of some combi- 
nation  of residues in regions  1-3. 
These chimeric molecules led us to conclude that the amino 
acids  that  determine  the V/3 specificity lie downstream  of 
amino acid 196. To test this hypothesis, we constructed the 
chimera SEA-SEE  195-196 as well as reciprocal region 4 ex- 
change mutants. These mutants again demonstrated that the 
COOH-terminal  region,  specifically  the  three  amino  acid 
dimorphisms in region 4, dictated the Vfl specificity of these 
toxins.  As with previous chimeras,  however, reduced levels 
of Vfl8 and Vfl5 were now observed. The effect of these three 
amino acid differences on the Vfl phenotype of the toxin was 
especially dramatic when comparing SEA-SEE(200-207) to 
SEA (Fig.  4). Mutation of these three amino acids in region 
4 elevated levels of V38 and depressed Vfl5 to background 
levels. The phenotype of the reciprocal constructions shown 
in Fig. 4 demonstrated that mutation of 200-207 in SEE to 
the SEA sequence could also depress Vfl8 stimulation  and 
elevate levels of VB5 (data not shown). These data demon- 
strate that analogous sites in SEA and SEE control stimula- 
tion of V35 and VBS, suggesting that one site on the mole- 
cule controls stimulation of all Vfls, rather than multiple TCR 
contact  sites  each controlling  the stimulation  of one Vfl. 
All Three  Amino Acid Dimorphisms in Region 4 Are Required 
for Complete Transfer of V~ Specificity.  To test the impor- 
tance of each of the three amino acid differences in region 
4,  we mutated  each individually.  We chose to mutate  the 
SEA molecule to the SEE sequence in these positions because, 
collectively, these three differences showed the most com- 
plete transfer of specificity when mutated from the SEA to 
the SEE sequence. Mutation of any of these amino acids in- 
dividually failed to transfer specificity completely, as judged 
by elevation of V38 and depression of VB5 (Fig. 5). Interest- 
ingly, each of the three individual mutations  showed a dis- 
tinct pattern. For the Ser--*Pro 206, V~8 levels were slightly 
I 
SEE  ....... 
SEE-SEA  ~  ~;~}~"~ ;  ;  " ~;~ ~ 
1161-195)  Io~  l 
SEA-SEE{  "" 
195-196 
Region 4 
SEA-SEE  ...... 
(2oo.~o~  I  ..  I 
SEA  I  I 
LIi  ￿9  v[35 
[] v~38 
0  2  4  6  8  10  12  14  16  "i8  20 
Percent Positive Blasts 
Figure 4.  Region 4  alone  me- 
diates  VB specificity in SEA  and 
SEE. Reciprocal exchange of region 
4,  containing  three  amino  acid 
differences (Fig. 3), inverted the V3 
stimulatory phenotype of the toxin. 
Note  that  levels  of  responding 
V38 +  T  cells were not  achieved 
unless both the NH2- and COOH- 
terminal regions  of the molecule 
were derived from one toxin. Re- 
sponding cell popuhtions  were typi- 
caUy >97%  CD3 positive with a 
background <0.3% positive when 
stained with GAM Ig FITC alone. 
Background  staining was not sub- 
tracted. 
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Figure  5.  All three amino acid dimorphisms  in re- 
gion 4 are required for full transfer of V/3 specificity, 
Each of the three amino acid mutations alone, all con- 
tained within region 4 (see Fig. 3), failed to transfer 
specifidty  from SEE to SEA as efficiently as all three 
together. 
elevated above those of VBS, whereas for the Gly--~Glu 200 
and Asn-~Glu 207, a reciprocal pattern was seen. This pat- 
tern was seen with T cells from all three of the individuals 
tested. 
NH2-terminal Residues Are Required  for Wild-Type Levels of 
V~8 Expression.  When we compared the levels of VB8 § 
T cells stimulated by SEE-SEA(161-195) and SEA-SEE 195- 
196 (Fig. 4), it was evident that sequences located upstream 
of amino acid 161 could complement the level of V/~8 ex- 
pression from 25 to 30% of that of native SEE to full wild- 
type levels. To map the sequences required to complement 
V~8 expression to wild-type levels, we superimposed the re- 
gion 4 of SEE on the chimera, SEE-SEA 70-71 (Fig. 6). The 
data demonstrated that the region of the toxin responsible 
for complementing V/38 levels back to those seen with na- 
tive SEE was located in the first 70 amino acids. The effect 
of region 4 on the VB stimulatory phenotype was particu- 
larly dramatic when comparing SEE-SEA 70-71 and SEE- 
SEA 71-71~SEA-SEE(200-207).  Substitution of the SEE re- 
gion 4 onto the SEE-SEA 70-71 chimera not only decreased 
VB5 levels to background, but also increased V/~8 to wild- 
type levels. 
The  NH2-terminal  Region Determines  Class II  Binding 
Phenotype  SEA and SEE bind class II molecules  with different 
affinities and most likely at slightly different sites. Because 
two reports have suggested that the site on the toxins that 
interacts  with  class II  molecules  is  located  in  the NH2- 
terminal region (18, 30), we tested the two chimeras, SEA- 
SEE(200-207) and SEE-SEA 70-71/SEA-SEE (200-207), for 
class II binding phenotype. The data demonstrate that SEA- 
SEE(200-207) bound class II molecules in a fashion similar 
to SEA, whereas SEE-SEA 70-71/SEA-SEE (200-207) bound 
class II molecules similar to SEE (Fig. 7). Thus, the NH2- 
terminal region of SEA and SEE determined their character- 
istic abilities to bind MHC class II molecules, consistent with 
previous reports. Furthermore, class II binding assays of SEA- 
SEE 142-143, 160-161, 187-188, 219-220, and SEE-SEA 70- 
71 indicated that the chimeric nature of these molecules did 
not perturb their ability to bind class II molecules (data not 
shown). 
Proliferative Capacity of Selected Chimeric Toxins.  Our data 
have shown that chimeric toxins that contained NH2 and 
COOH regions from different toxins stimulated lower per- 
centages of Vfl5 + or Vfl8 + T cells than that seen with the 
wild-type toxins  or with toxins  that had both NH2-  and 
COOH-terminal regions derived from a single toxin. To in- 
SEA  I  I~ 
￿9  vp5 
[] v~8 
SEE-SEA  I,  ,,  ~I,~i~1  I  ~ 
70-71 
Region 4 
SEA-SEE 
(200-207)  I  H  I~'///////////////////,~ 
SEA-SEE (200-207)  SEE-SEA 70-71,  ................................................. ~,,  II  I~//////////////////,/b  ~1 
~///////,,////////////d--q 
2  4  6  0  10  12  14 
Percent Positive Blasts 
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Figure  6.  Residues upstream of 
amino acid 70 restored  wild-type 
levels of VI~8 stimuhtion to those 
seen with native  SEE. 3.0 
u  ~  2.5 
C 
== 
2.0  LL 
:= 
o= 
n- 
1.5 
1.0 
--  ~l  SEA peptide 
I~:!~:~,t  |~1  I SEE-SEA  70-71/ 
SEA-SEE(200-207) 
[  ]  SEA 
I  |i|  I SEA-SEE(200-207) 
Background 
........  i  ........  i 
10  100  IOO0 
Competitor Conc. (nM) 
Figure 7.  NHz-terminal 70  amino acids determine 
class II binding characteristics of SEA and SEE. SEA- 
SEE(200-207) competed with FITC-SEA for binding to 
DRl-transfected L cells similarly to wild-type SEA de- 
rived from E.  coil  SEE-SEA 70-71/SEA-SEE(200-207) 
competed with FITC-SEA poorly for binding  to DR1 simi- 
larly to wild-type SEE. Data are expressed in linear fluores- 
cence units and are from one experiment  representative 
of two done. 
vestigate whether this reduced level of V/3-specific stimula- 
tion was due to decreased mitogenic potency of the chimeras, 
we tested the ability of SEA-SEE(200-207)  and SEE-SEA 70- 
71/SEA-SEE (200-207) to stimulate T cell proliferation (Fig. 
8).  The  chimeric  molecules  were  equally  potent  T  cell 
mitogens, comparable to wild-type SEA, ruling out the pos- 
sibility that the reduced level of V/3-specific stimulation seen 
in some chimeras, such as SEA-SEE(200-207),  was due to 
decreased ability to stimulate T  cell proliferation. The mo- 
lecular basis of the greater potency of wild-type SEE, para- 
doxical in view of its much lower avidity for MHC class II, 
remains unexplained. 
Stimulation of  Mouse T Cells with Chimeric  Enterotoxins  Maps 
V# Specificity  to Region 4.  It is possible that the staphylococcal 
enterotoxins contain several sites that contact the TCR, each 
controlling one type of V/~-specific  T cell response. This model 
might explain why all toxins stimulate T cells that bear sev- 
eral types of V/~ segments. The alternate hypothesis is that 
one site on the toxin crossreacts with several different V/3 
segments. Mapping more than one set of V/5-specific  reciprocal 
stimulating activities to region 4 would support the latter 
model. Therefore, we tested selected chimeric toxins from 
our panel for their ability to stimulate T cells from B10.BR 
mice and assessed the phenotype of the responding cells with 
V/5-spedfic mAbs. Many of the initial chimeras demonstrated 
mixed patterns of V/~-specific T  cell activation as was seen 
with human T  cell responses (data not shown). However, 
mouse T  cell responses to the region 4 exchange mutants 
as well as SEE-SEA 70-71~SEA-SEE(200-207) dearly demon- 
strated that VB3- or V~11-spedfic T cell responses in B10.BR 
mice also converge upon region 4  (Table 2). 
Discussion 
We used the approach of constructing chimeric enterotoxin 
genes to map important functional activities on these mole- 
cules.  In construction, we took advantage of the fact that 
the two enterotoxins most closely related structurally, SEA 
and SEE, differ with respect to two important immunolog- 
ical parameters. First, SEA stimulates human T cells that bear 
VB5 and not V/58, whereas SEE shows the opposite stimula- 
tory phenotype (23). Second, SEA binds class II with a rela- 
tively high affinity, whereas SEE binds class II molecules with 
an affinity so low as to be almost undetectable (24, 25). Given 
these  dimorphisms  and  their  high  degree  of  structural 
similarity, we assumed that chimeric molecules should re- 
20. 
/If  ~\ 
i  /--..~//  -%  r--  =~SEA 
15.  /  J/  -  I  H  , SEA-SEE(200-2OT) 
~o  /-  FJ  ~  ............  SEE-SEA 70-71/ 
￿9  --  /  ~J  SEA-SEE(200-2O7) 
s# 
.001  .01  .1  1  10 
Toxin Concentration (ng/ml) 
Figure 8.  Chimeric enterotoxins are not impaired in 
their ability to stimulate T cell-proliferative responses. 
PBMC (8  x  104)  were incubated with threefold dilutions 
of purified SEA-SEE(2(D-207)  and SEE-SEA(70-71)/SEA- 
SEE(200-207) in round-bottomed 96-well plates. Prolifer- 
ation was assessed on day 2 with an 18-h [3H]TdR pulse. 
SEMs of triplicate responses were <10% of the mean for 
all points shown. 
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Chimeric Enterotoxins 
Percent positive blasts 
Toxin  V33  V311  V139 
SEA  30  12  1 
SEE  3  56  1 
SEA-SEE(161-195)  32  14  1 
SEE-SEA(161-195)  3  60  1 
SEA-SEE 195-196  22  20  1 
SEE-SEA 195-196  44  6  1 
SEA-SEE(200-207)  19  20  1 
SEE-SEA(200-207)  44  6  1 
SEE-SEA 70-71/ 
SEA-SEE(200-207)  6  65  1 
B10.BR splenic T  cells were stimulated with chimeric  enterotoxins in 
vitro for 4 d as previously  described (20). Concentrations of the toxins 
used were 1/~g/ml for GF-purified toxins and 0.1/~g/ml for AP-purified 
toxins. Cells were stained with mAbs specific for the indicated V~ seg- 
ment, and the blast cell population was analyzed by flow cytometry. All 
T  cell blasts  were >97%  positive for CD3.  Data were from one ex- 
periment. 
tain  these  two distinct  phenotypes, allowing  them to be 
mapped genetically. This approach has several advantages. It 
allows one to study the enterotoxins with all functions in- 
tact, obviating the problems inherent in biochemical or genetic 
fragmentation of the molecule. More importantly, functions 
can be studied by changing them to new functions instead 
of knocking them out, providing a higher degree of surety 
that identified regions of interest are directly involved in the 
observed phenotypic changes. 
Using this  approach,  we identified  a three-amino acid 
dimorphism between SEA and SEE that is responsible for 
the differential stimulation of human V/35 or V38 and mouse 
VB3 or V~11 T cells. These three amino acids are located 
near the COOH-terminal end of the molecule (last 15% of 
the linear sequence), and all three dimorphic amino acids play 
a role in preferential stimulation of one specific  TCR VB seg- 
ment versus another. Although these three amino acid differ- 
ences determine most of the V3 specificity, we cannot say 
how many of the surrounding amino acids that are identical 
between the two toxins are involved in direct contact with 
the TCR. Thus, this area of the toxin may resemble a type 
of framework/complementarity-determining  region arrange- 
ment in which some relatively constant residues in the toxin 
strengthen the interaction with the TCR, whereas other poly- 
morphic residues may confer specificity. We can say that the 
upstream boundary of the site must lie distal to amino acid 
195 (i.e., the end of region 3) because exchanging region 3 
between SEA and SEE had no effect  on the stimulatory pheno- 
type of the two toxins. 
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In addition to  mapping  a V3-determining site  to  the 
COOH terminus, we used these chimeric molecules to map 
the region of the toxin that interacts with class II molecules 
to the first 70 amino acids of the NH2 terminus. These data 
are consistent with work from other laboratories suggesting 
that class II binding activity lies near the NH2 terminus. For 
example, using a synthetic peptide approach, Pontzer et al. 
(30) reported that peptides derived from the NH2 terminus 
block SEA binding to class II molecules. Also, Kappler et 
al. (18) showed that mutations located in the NH2 terminus 
could drastically reduce the class II binding activity of SEB. 
The class II binding assays (Fig. 7) also support previous reports 
that SEA and SEE bind class II molecules with different af~ni- 
ties (24). Interestingly, we have mapped a second activity to 
the first 70 amino acids of SEE that when combined with 
the V38-specific contact site at the COOH terminus stimu- 
lated wild-type levels of V38. When this NH2-terminal site 
of one toxin was forced to interact with the V/3-determining 
region of the other,  as in the chimeras, wild-type levels of 
appropriate Vj3-specific  stimulation were not achieved. These 
data most likely indicate that both the NH2- and COOH- 
terminal ends of SEA and SEE contribute to the site on the 
toxins that contacts the variable segment of the TCK B chain. 
Thus, the amino acids 200-207  might be located adjacent 
to NH2-terminal amino acids in the three-dimensional struc- 
ture of the molecule, forming a conformational determinant 
that is responsible for TCR. contact and Vfl specificity. Re- 
cent studies of the crystal structure of SEB demonstrates that 
both NH2- and COOH-terminal ends of this superantigen 
are closely  apposed and contribute to a shallow pocket predicted 
to contact the TCR (31). Other amino acids predicted to lie 
in this binding site are derived from the middle part of the 
molecule. However, since this middle region of the protein 
is highly conserved between SEA and SEE, these residues, 
though located in the TCR binding cleft, are not the ones 
responsible for VB5 or Vfl8 discrimination. 
Our data also support the SEB structure-function model 
advanced by Kappler et al. (18). These authors reported that 
randomly introduced mutations  localized  both  the  class 
II-binding and TCR contact sites to the NH2 terminus of 
SEB. We have also mapped to the first 70 amino acids of SEA 
and SEE two activities, one that controls class II binding and 
a second that contributes to V/3 specificity. These data are 
compatible with the suggestion that the class II-binding and 
part of the VB-contact  sites of bacterial superantigens  are 
closely associated and perhaps intertwined in the NH2 ter- 
minus of these molecules. However, preliminary data from 
our laboratory indicated that this second V3 contact site in 
the NH2 terminus can be completely separated from the site 
on the molecule that determines class II binding characteris- 
tics, suggesting that the class II binding site and both Vf3 
contact sites are distinct and separable on the primary struc- 
ture of the molecule (J. Lamphear and R. Rich, unpublished 
observations). 
Bacterial superantigens typically demonstrate specificity  for 
two or more TCR V3 segments. Our data support the con- 
clusion that these toxins contain one V3 contact site that 
crossreacts with several different V3s.  This contrasts  to a second possibility in which there may be two or more TCR 
contact sites on the enterotoxins, each interacting with one 
VB. Two human VB-stimulating activities specific for VB5 
and VB8  mapped to the same region of SEA/SEE, as did 
stimulation of mouse VB3 and V/511. Human VB8 and mouse 
V~ll  are ancestral  homologues, whereas the human VB5 
family and mouse VB3  are not related evolutionarily (32). 
Thus, our data have mapped three distinct V/~ stimulatory 
activities to region 4 (amino acids 200-207), which suggests, 
but does not prove, that all VB-specific activation is controlled 
by this  COOH-terminal  region or  a  combination of the 
NH2-  and  COOH-terminal  regions.  Analysis of the  VB 
usage by chimeric toxin-activated T  cell blasts  using quan- 
titative PCR should indicate whether stimulation of all V~s 
are controlled by the COOH  terminus or only a subset. 
Lastly, our model is somewhat similar to that now being 
proposed for MMTV-encoded endogenous superantigens. The 
localization of polymorphisms between the different viral su- 
perantigens suggests that the COOH terminus of these su- 
perantigens controls their VB specificity as well (33). A broadly 
similar design between these two families suggests either a 
very old relationship and a case of divergent evolution or a 
striking case of convergent evolution. Our demonstration of 
the utility of creating chimeric superantigens to map func- 
tionally significant regions of SEA and SEE suggests that this 
approach may be more broadly applicable to other superan- 
tigens. 
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